These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 16157380

  • 1. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T, Funatsu H, Uchigata Y, Kitano S, Shimizu E, Amano S, Yamagami S, Noma H, Araie M, Hori S.
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [Abstract] [Full Text] [Related]

  • 2. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.
    Mimura T, Funatsu H, Uchigata Y, Kitano S, Shimizu E, Noma H, Amano S, Araie M, Iwamoto Y, Hori S.
    Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939
    [Abstract] [Full Text] [Related]

  • 3. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.
    Immunol Lett; 2005 Jul 15; 99(2):180-5. PubMed ID: 16009268
    [Abstract] [Full Text] [Related]

  • 4. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R, Gombos Z, Gyürüs E, Soltész G.
    Orv Hetil; 2003 Feb 23; 144(8):355-60. PubMed ID: 12666382
    [Abstract] [Full Text] [Related]

  • 5. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.
    Horm Metab Res; 1997 Oct 23; 29(10):510-5. PubMed ID: 9405979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitus.
    Mimura T, Funatsu H, Uchigata Y, Kitano S, Noma H, Shimizu E, Konno Y, Amano S, Araie M, Yoshino O, Iwamoto Y, Hori S.
    Am J Ophthalmol; 2003 Jun 23; 135(6):844-8. PubMed ID: 12788125
    [Abstract] [Full Text] [Related]

  • 8. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E.
    Diabetologia; 2002 Sep 23; 45(9):1298-306. PubMed ID: 12242463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G, Auinger M, Clodi M, Prischl F, Kramar R, Diabetic Nephropathy Study Group of the Austrian Society of Nephrology.
    Nephrol Dial Transplant; 2005 Mar 23; 20(3):559-65. PubMed ID: 15671073
    [Abstract] [Full Text] [Related]

  • 11. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
    Maugendre D, Sonnet E, Derrien C, Le Golff MC, Grais MC, Allannic H, Delamaire M.
    Diabetes Metab; 1999 Mar 23; 25(1):28-33. PubMed ID: 10335421
    [Abstract] [Full Text] [Related]

  • 12. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T.
    J Clin Endocrinol Metab; 2001 Feb 23; 86(2):574-82. PubMed ID: 11158011
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N, Takino H, Yano M, Kawasaki E, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S.
    J Autoimmun; 1996 Oct 23; 9(5):683-8. PubMed ID: 8933285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark Å, Pociot F, Danish Study Group of Childhood Diabetes.
    Autoimmunity; 2011 Mar 23; 44(2):107-14. PubMed ID: 20836749
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I.
    Diabet Med; 2005 Apr 23; 22(4):448-52. PubMed ID: 15787671
    [Abstract] [Full Text] [Related]

  • 17. [Subclassification of seronegative type 1 diabetic subjects with HLA-DQ genotypes].
    Zhang DM, Zhou ZG, Zhang C, Huang G, Jin P, Wang JP, Wei JL, Hu BY.
    Zhonghua Nei Ke Za Zhi; 2004 Mar 23; 43(3):174-8. PubMed ID: 15059369
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I, Conrad K, Füssel M, Henker J.
    Dtsch Med Wochenschr; 2003 Jan 31; 128(5):185-9. PubMed ID: 12557109
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 Jan 31; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

  • 20. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY, Huang P, Lou HL.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug 31; 23(8):868-9. PubMed ID: 12919925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.